Clinical Trials
56 trialsCOARC
University of Texas Southwestern Medical Center
exBOND
CG Oncology, Inc.
BOOST
Relmada Therapeutics, Inc.
Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial
National Cancer Institute (NCI)
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
VA Office of Research and Development
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
Guangzhou Red Pine Medical Instrument Co., Ltd.
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
ABLE-42
Ferring Pharmaceuticals
VS-UrineID
University of Kansas Medical Center
ISABELLA
University of Aberdeen
Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)
EMD Serono
TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Brown University
A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial
Second Xiangya Hospital of Central South University
ARTGU
University Health Network, Toronto
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy
University of Kansas Medical Center
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
QuantumLeap Healthcare Collaborative
Vaccine Response With NT-I7
National Institutes of Health Clinical Center (CC)
Rideau
University of British Columbia
sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer
University of Southern California
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Pfizer
Low-moderate Intensity Pedaling During Immunotherapy Administration
Rush University Medical Center
FL- 101 Study in Non-Metastatic MIBC
Flame Biosciences
(BLASST)-3
Dana-Farber Cancer Institute
Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors
Case Comprehensive Cancer Center
Mapping 3D Bladder
University Health Network, Toronto
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
UNC Lineberger Comprehensive Cancer Center
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
NKGen Biotech, Inc.
A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102
Eisai Inc.
TRIO Bladder
Duke University
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
H. Lee Moffitt Cancer Center and Research Institute
A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)
Tocagen Inc.
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
Dana-Farber Cancer Institute
Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer
University of Wisconsin, Madison
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Stanford University
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
University of Southern California
RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Medical Enterprises Europe B.V.
PACT CREATE 3
VA Office of Research and Development
JaNEO
Ligartis GmbH
Improving Sensitivity of Urine Cytology for Bladder Cancer
Johns Hopkins University
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
University of California, San Francisco
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
Washington University School of Medicine
Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer
Case Comprehensive Cancer Center
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Alliance for Clinical Trials in Oncology
NMIBC TURBT HG
UroGen Pharma Ltd.
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
GE Healthcare
SHTC-EUROPE-1
Medical Enterprises Europe B.V.
First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC
Bioniche Life Sciences Inc.
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
Stanford University